BNP Paribas Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.62M Buy
351,630
+46,569
+15% +$1.1M 0.01% 724
2025
Q4
$7.57M Buy
305,061
+304,650
+74,124% +$8.09M 0.01% 744
2025
Q3
$12K Hold
411
﹤0.01% 1587
2025
Q2
$10K Buy
+411
New +$11.6K ﹤0.01% 1795

Other funds holding ASTH

BNP Paribas Asset Management's ASTH Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Astrana Health (ASTH) stake by 15% in Q1 2026, buying an estimated $1.1M and bringing the position to 351,630 shares worth $8.62M. The position accounts for 0.01% of the portfolio, ranked #724.

BNP Paribas Asset Management first reported a position in ASTH in Q2 2025 and has held it in 4 quarters since. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • BNP Paribas Asset Management held 351,630 shares of Astrana Health worth $8.62M as of Q1 2026.
  • BNP Paribas Asset Management bought 46,569 Astrana Health shares in Q1 2026, an estimated $1.1M.
  • Astrana Health made up 0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #724 holding.
  • BNP Paribas Asset Management first reported a position in Astrana Health in Q2 2025 and has held it in 4 quarters since.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.